Tokyo, Japan

Kensaku Okano

This inventor holds 1 USPTO granted patent. Top assignee: Hodogaya Chemical Co., Ltd.. Active years: 1990.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 1990

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kensaku Okano: Innovator in Pentadiene Amino Compounds

Introduction

Kensaku Okano is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pentadiene amino compounds. His innovative work has led to the filing of a patent that showcases his expertise and creativity in this area.

Latest Patents

Kensaku Okano holds a patent for a pentadiene amino compound. The compound is characterized by the formula: ##STR1##, wherein each of R₁, R₂, R₃, and R₄ is a C₁-C₄ alkyl group or a substituted or unsubstituted aryl or aralkyl group. Additionally, R₅ is an alkyl group, and X can be a hydrogen atom, a C₁-C₄ alkyl group, a C₁-C₄ alkoxy group, or a halogen atom. This patent highlights his innovative approach to chemical compounds and their potential applications.

Career Highlights

Kensaku Okano is associated with Hodogaya Chemical Co., Ltd., where he continues to contribute to advancements in chemical research and development. His work at the company has allowed him to explore various aspects of chemical innovation, leading to his successful patent.

Collaborations

Kensaku Okano has collaborated with notable colleagues, including Kazuo Kaneko and Masahiko Yamaguchi. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of new technologies.

Conclusion

Kensaku Okano is a distinguished inventor whose work in pentadiene amino compounds has made a significant impact in the field of chemistry. His patent and collaborations reflect his dedication to innovation and advancement in chemical research.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…